Filters
Filters

 

Resource Type
Topic
Show (105)
Cancel
Nav1.5(Late) Cardiac Safety Assay on QPatch
August 31, 2019
Read More
Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline
July 31, 2019
Read More
An Interview with Professor Nikita Gamper
July 2, 2019
Read More
ELRIG: Advances in Cell Based Screening – Gothenburg, Sweden
July 2, 2019
Read More
Ion Channels in Drug Discovery XIX – Satellite event at BPS 2019
May 28, 2019
Read More
A summary of the Sixth Cambridge Ion Channel Forum
May 3, 2019
Read More
Metrion Biosciences appoints Dr Andrew Southan as Chief Executive Officer
April 8, 2019
Read More
Metrion Biosciences Closes Funding Round
April 1, 2019
Read More
Metrion Biosciences and LifeArc sign collaboration agreement for neuroscience-focused ion channel drug discovery
January 29, 2019
Read More
An Interview with Professor Alistair Mathie
November 26, 2018
Read More
1 … 6 7 8 9 10 11
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram